Physician
Rheumatology
Vibeke C. Strand practices Rheumatology. She attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. She received awards:"Who's Who in Science and Engineering", "Associate Investigator" and "Postgraduate Fellow". Vibeke Strand is a published doctor. She published 29 publications, including: 'Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.'
Publications
- The impact of biologic treatment on use of mechanical devices among rheumatoid arthritis patients in a large united states patient registry.
- Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musc...
- Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
- Development and validation of the lupus impact tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.
- Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: Patient-reported outcomes from a Phase 3 trial.
- Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain.
- Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Intersti...
- OMERACT 11: International Consensus Conference on Outcome Measures in Rheumatology.
- Putting the value into biosimilar decision making: The judgment value criteria.
- Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...
- OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout.
- Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE tri...
- The utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis: Report from the imaging group of the...
- Predictors of self-reported health-related quality of life in systemic lupus erythematosus.
- Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study.
- Response to M. Boers' concerns about spydergrams.
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled...
- Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus eryt...
- Prevalence of axial SpA in US rheumatology practices: Assessment of ASAS criteria vs. rheumatology expert clinical diagnosis.
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, pl...
- Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: ...
- Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Ra...
- Impact of rheumatoid arthritis disease activity test on clinical practice.
- Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to ...
- Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimum...
- Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey.
- Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phas...
- Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.
Schools
University of California At San Francisco
Mich State University Assoc Hospital
Doctors Specialties
Accepted Insurances
Awards
- Who's Who in Science and Engineering
- Associate Investigator
- Postgraduate Fellow
Education
-
University of California San Francisco School of Medicine
Hospital
-
Stanford Health Care
-
VA Palo Alto Health Care System
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.